Abstract
ImportanceIn combination with a decreased risk of AIDS-defining cancers and improved survival of people infected with HIV, the burden of non–AIDS-defining cancer has increased markedly. Although a substantial number of studies have measured the cancer risk among people with HIV in developed countries, little research has been conducted on the risk of cancer in HIV-infected people in Asia.ObjectiveTo examine the cancer incidence and the estimated risk of cancer among people in Korea infected with HIV compared with the general population.Design, Setting, and ParticipantsThis retrospective cohort study evaluated patients without cancer newly diagnosed with HIV from January 1, 2006, to December 31, 2018, using a nationwide population-based claims database embedded in the National Health Insurance Service database. Data were analyzed between December 6, 2021, and February 28, 2022.ExposuresInfection with HIV.Main Outcomes and MeasuresCancer incidence and standardized incidence rate (SIR) through indirect standardization.ResultsA total of 11 552 individuals without cancer (10 444 male [90.4%]; mean [SD] age, 39.9 [11.2] years) diagnosed with HIV were identified. The SIR for all cancers was 1.68 (95% CI, 1.50-1.87) in men and 1.26 (95% CI, 0.89-1.64) in women. In men, the highest SIRs were for Kaposi sarcoma (SIR, 349.10; 95% CI, 196.10-502.20) and anal cancer (SIR, 104.20; 95% CI, 55.56-149.90). The incidence of non-Hodgkin lymphoma (SIR, 15.62; 95% CI, 11.85-19.39), Hodgkin lymphoma (SIR, 16.67; 95% CI, 4.32-29.02), and oropharyngeal cancer (SIR, 2.97; 95% CI, 1.36-4.58) in men infected with HIV was higher than in the general population. In women infected with HIV, an increased incidence of cervical cancer (SIR, 4.98; 95% CI, 1.29-8.66) and non-Hodgkin lymphoma (SIR, 11.78; 95% CI, 2.35-21.21) compared with the general population was observed. The SIR of thyroid cancer in patients with HIV was lower than in the general population in both men (SIR, 0.63; 95% CI, 0.27-0.99) and women (SIR, 0.48; 95% CI, 0.06-0.90).Conclusions and RelevanceIn this cohort study, cancer risks, especially AIDS-defining cancer and virus-related cancer, were elevated in people with HIV. Efforts for cancer prevention, screening, and better accessibility to medical care in HIV-infected people are warranted.
Topics

No keywords indexed for this article. Browse by subject →

References
34
[1]
Yarchoan "HIV-Associated cancers and related diseases." N Engl J Med (2018) 10.1056/nejmra1615896
[2]
Shiels "Projected cancer incidence rates and burden of incident cancer cases in HIV-infected adults in the United States through 2030." Ann Intern Med (2018) 10.7326/m17-2499
[3]
Yoo "Characteristics of adolescents and young adults with HIV in the Republic of Korea from 2010 through 2015." Sci Rep (2020) 10.1038/s41598-020-66314-0
[4]
Kim "History of acquired immune deficiency syndrome in Korea." Infect Chemother (2020) 10.3947/ic.2020.52.2.234
[5]
Bahk "Using the National Health Information Database of the National Health Insurance Service in Korea for monitoring mortality and life expectancy at national and local levels." J Korean Med Sci (2017) 10.3346/jkms.2017.32.11.1764
[6]
Kim "Impact of the policy of expanding benefit coverage for cancer patients on catastrophic health expenditure across different income groups in South Korea." Soc Sci Med (2015) 10.1016/j.socscimed.2015.06.012
[7]
Hernández-Ramírez "Cancer risk in HIV-infected people in the USA from 1996 to 2012: a population-based, registry-linkage study." Lancet HIV (2017) 10.1016/s2352-3018(17)30125-x
[8]
Hessol "Incidence of first and second primary cancers diagnosed among people with HIV, 1985-2013: a population-based, registry linkage study." Lancet HIV (2018) 10.1016/s2352-3018(18)30179-6
[9]
Park "Time trends in cancer incidence in persons living with HIV/AIDS in the antiretroviral therapy era: 1997-2012." AIDS (2016) 10.1097/qad.0000000000001112
[10]
Franceschi "Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study." Br J Cancer (2010) 10.1038/sj.bjc.6605756
[11]
Hleyhel "Risk of AIDS-defining cancers among HIV-1-infected patients in France between 1992 and 2009: results from the FHDH-ANRS CO4 cohort." Clin Infect Dis (2013) 10.1093/cid/cit497
[12]
Robbins "Epidemiologic contributions to recent cancer trends among HIV-infected people in the United States." AIDS (2014) 10.1097/qad.0000000000000163
[13]
Engels "Cancer risk in people infected with human immunodeficiency virus in the United States." Int J Cancer (2008) 10.1002/(issn)1097-0215
[14]
Chen "Cancer incidence in a nationwide HIV/AIDS patient cohort in Taiwan in 1998-2009." J Acquir Immune Defic Syndr (2014) 10.1097/qai.0000000000000065
[15]
Lee "Trends in malignancies among Korean patients infected with human immunodeficiency virus in the highly active antiretroviral therapy era." J Korean Med Sci (2017) 10.3346/jkms.2017.32.9.1445
[16]
Hleyhel "Risk of non-AIDS-defining cancers among HIV-1-infected individuals in France between 1997 and 2009: results from a French cohort." AIDS (2014) 10.1097/qad.0000000000000382
[17]
Kim "Significance of decreasing rate of HIV and HBV co-infection in a nationwide Korean HIV/AIDS cohort." J Korean Med Sci (2020) 10.3346/jkms.2020.35.e7
[18]
Cho "Current status and strategies for hepatitis B control in Korea." Clin Mol Hepatol (2017) 10.3350/cmh.2017.0104
[19]
Kim "Opportunistic diseases among HIV-infected patients: a multicenter-nationwide Korean HIV/AIDS cohort study, 2006 to 2013." Korean J Intern Med (2016) 10.3904/kjim.2014.322
[20]
Gunter "Cigarette smoking in South Korea: a narrative review." Korean J Fam Med (2020) 10.4082/kjfm.18.0015
[21]
Mirza "Endocrinological aspects of HIV infection." J Endocrinol Invest (2018) 10.1007/s40618-017-0812-x
[22]
Properzi "Low prevalence of symptomatic thyroid diseases and thyroid cancers in HIV-infected patients." Sci Rep (2019) 10.1038/s41598-019-56032-7
[23]
Bray "Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries." CA Cancer J Clin (2018) 10.3322/caac.v68.6
[24]
Ahn "Korea’s thyroid-cancer “epidemic”—screening and overdiagnosis." N Engl J Med (2014) 10.1056/nejmp1409841
[25]
Sung "Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries." CA Cancer J Clin (2021) 10.3322/caac.v71.3
[26]
Coghill "Risk of breast, prostate, and colorectal cancer diagnoses among HIV-infected individuals in the United States." J Natl Cancer Inst (2018) 10.1093/jnci/djy010
[27]
Shiels "Reduced risk of prostate cancer in US men with AIDS." Cancer Epidemiol Biomarkers Prev (2010) 10.1158/1055-9965.epi-10-0741
[28]
Choi "Epidemiological characteristics of HIV infected Korean: Korea HIV/AIDS Cohort Study." Epidemiol Health (2019) 10.4178/epih.e2019037
[29]
Lin "Human papillomavirus prevalence and behavioral risk factors among HIV-infected and HIV-uninfected men who have sex with men in Taiwan." Medicine (Baltimore) (2018) 10.1097/md.0000000000013201
[30]
Farahmand "Prevalence and genotype distribution of human papillomavirus infection in different anatomical sites among men who have sex with men: a systematic review and meta-analysis." Rev Med Virol (2021) 10.1002/rmv.v31.6
[31]
Kim "Current status of human papillomavirus infection and introduction of vaccination to the National Immunization Program in Korea: an overview." J Korean Med Sci (2018) 10.3346/jkms.2018.33.e331
[32]
Kim "Mode of human immunodeficiency virus transmission in Korea: the Korea HIV/AIDS Cohort Study." Korean J Med (2018) 10.3904/kjm.2018.93.4.379
[33]
Frisch "Association of cancer with AIDS-related immunosuppression in adults." JAMA (2001) 10.1001/jama.285.13.1736
[34]
Korea Center for Disease Control Prevention (2021)
Cited By
30
Signal Transduction and Targeted Th...
International Journal of Molecular...
Metrics
30
Citations
34
References
Details
Published
Aug 02, 2022
Vol/Issue
5(8)
Pages
e2224897
Authors
Cite This Article
Boyoung Park, Kyoung Hwan Ahn, Yunsu Choi, et al. (2022). Cancer Incidence Among Adults With HIV in a Population-Based Cohort in Korea. JAMA Network Open, 5(8), e2224897. https://doi.org/10.1001/jamanetworkopen.2022.24897